These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 20484178)

  • 21. Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial.
    Blanco I; Santos S; Gea J; Güell R; Torres F; Gimeno-Santos E; Rodriguez DA; Vilaró J; Gómez B; Roca J; Barberà JA
    Eur Respir J; 2013 Oct; 42(4):982-92. PubMed ID: 23429918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sildenafil citrate for the prevention of high altitude hypoxic pulmonary hypertension: double blind, randomized, placebo-controlled trial.
    Bates MG; Thompson AA; Baillie JK; Sutherland AI; Irving JB; Hirani N; Webb DJ
    High Alt Med Biol; 2011; 12(3):207-14. PubMed ID: 21962063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sildenafil in idiopathic pulmonary fibrosis.
    Rossi GP; Seccia TM
    N Engl J Med; 2010 Nov; 363(22):2169-70; author reply 2170-1. PubMed ID: 21105803
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study.
    Sastry BK; Narasimhan C; Reddy NK; Raju BS
    J Am Coll Cardiol; 2004 Apr; 43(7):1149-53. PubMed ID: 15063421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sildenafil citrate in the treatment of pain in primary dysmenorrhea: a randomized controlled trial.
    Dmitrovic R; Kunselman AR; Legro RS
    Hum Reprod; 2013 Nov; 28(11):2958-65. PubMed ID: 23925396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sildenafil improves walk distance in idiopathic pulmonary fibrosis.
    Collard HR; Anstrom KJ; Schwarz MI; Zisman DA
    Chest; 2007 Mar; 131(3):897-899. PubMed ID: 17356110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease.
    Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG
    Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sildenafil for pulmonary hypertension: need for evidence generation.
    Shafiq N; Reddy S; Pandhi P; Manoj R; Talwar KK; Malhotra S
    Int J Clin Pharmacol Ther; 2008 Dec; 46(12):644-51. PubMed ID: 19049698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
    Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
    Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial.
    Goldberg DJ; French B; McBride MG; Marino BS; Mirarchi N; Hanna BD; Wernovsky G; Paridon SM; Rychik J
    Circulation; 2011 Mar; 123(11):1185-93. PubMed ID: 21382896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventilatory efficiency and dyspnea on exertion improvements are related to reduced pulmonary pressure in heart failure patients receiving Sildenafil.
    Guazzi M; Myers J; Peberdy MA; Bensimhon D; Chase P; Arena R
    Int J Cardiol; 2010 Oct; 144(3):410-2. PubMed ID: 19329196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial.
    Ghofrani HA; Reichenberger F; Kohstall MG; Mrosek EH; Seeger T; Olschewski H; Seeger W; Grimminger F
    Ann Intern Med; 2004 Aug; 141(3):169-77. PubMed ID: 15289213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sildenafil improves skeletal muscle oxygenation during exercise in men with intermittent claudication.
    Roseguini BT; Hirai DM; Alencar MC; Ramos RP; Silva BM; Wolosker N; Neder JA; Nery LE
    Am J Physiol Regul Integr Comp Physiol; 2014 Aug; 307(4):R396-404. PubMed ID: 24944249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: a systematic review.
    Wang RC; Jiang FM; Zheng QL; Li CT; Peng XY; He CY; Luo J; Liang ZA
    Respir Med; 2014 Mar; 108(3):531-7. PubMed ID: 24462476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.
    Tapson VF; Torres F; Kermeen F; Keogh AM; Allen RP; Frantz RP; Badesch DB; Frost AE; Shapiro SM; Laliberte K; Sigman J; Arneson C; Galiè N
    Chest; 2012 Dec; 142(6):1383-1390. PubMed ID: 22628490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity.
    Machado RF; Barst RJ; Yovetich NA; Hassell KL; Kato GJ; Gordeuk VR; Gibbs JS; Little JA; Schraufnagel DE; Krishnamurti L; Girgis RE; Morris CR; Rosenzweig EB; Badesch DB; Lanzkron S; Onyekwere O; Castro OL; Sachdev V; Waclawiw MA; Woolson R; Goldsmith JC; Gladwin MT;
    Blood; 2011 Jul; 118(4):855-64. PubMed ID: 21527519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral sildenafil therapy for Chinese patients with pulmonary arterial hypertension: a multicenter study.
    Xiong CM; Lu XL; Shan GL; Wu BX; Zhu XY; Wu GH; Zeng XF; Guo T; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Tian HY; Li WM; Zhang DZ; Zhang C; Li MT; Liu HM; Guo YJ; Shen JY; Zhang WJ; Liu S; Zhou DX; Bao CD; Huang SA; Chen JY; Wu WF; Huang K; Li CL; Wang LH; He B; He JG; Li JJ
    J Clin Pharmacol; 2012 Mar; 52(3):425-31. PubMed ID: 21415281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy and safety of sildenafil therapy in pulmonary artery hypertension: a meta-analysis].
    Kuang TG; Wang J; Zhai ZG; Guo XH; Wang C
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1021-4. PubMed ID: 17672963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
    Madden BP; Sheth A; Wilde M; Ong YE
    Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
    Mathai SC; Girgis RE; Fisher MR; Champion HC; Housten-Harris T; Zaiman A; Hassoun PM
    Eur Respir J; 2007 Mar; 29(3):469-75. PubMed ID: 17079256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.